NO963029L - Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod - Google Patents

Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod

Info

Publication number
NO963029L
NO963029L NO963029A NO963029A NO963029L NO 963029 L NO963029 L NO 963029L NO 963029 A NO963029 A NO 963029A NO 963029 A NO963029 A NO 963029A NO 963029 L NO963029 L NO 963029L
Authority
NO
Norway
Prior art keywords
peripheral blood
stimulate
blood cells
core peripheral
cytological activity
Prior art date
Application number
NO963029A
Other languages
English (en)
Norwegian (no)
Other versions
NO963029D0 (no
Inventor
Martin A Schwarz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO963029D0 publication Critical patent/NO963029D0/no
Publication of NO963029L publication Critical patent/NO963029L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO963029A 1994-01-20 1996-07-19 Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod NO963029L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN94194863A CN1142186A (zh) 1994-01-20 1994-01-20 用白介素-10激活外周血单核细胞的细胞溶解活性
PCT/IB1994/000008 WO1995019780A1 (en) 1994-01-20 1994-01-20 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity

Publications (2)

Publication Number Publication Date
NO963029D0 NO963029D0 (no) 1996-07-19
NO963029L true NO963029L (no) 1996-09-19

Family

ID=37708148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963029A NO963029L (no) 1994-01-20 1996-07-19 Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod

Country Status (10)

Country Link
EP (1) EP0740552A1 (pl)
JP (1) JPH09508116A (pl)
CN (1) CN1142186A (pl)
AU (1) AU707019B2 (pl)
FI (1) FI962813L (pl)
NO (1) NO963029L (pl)
NZ (1) NZ259584A (pl)
PL (1) PL175343B1 (pl)
SK (1) SK91696A3 (pl)
WO (1) WO1995019780A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685931B1 (en) 1998-12-22 2004-02-03 Schering Corporation Treatment of hepatitis C virus infections with interleukin-10
ATE516820T1 (de) 2000-09-29 2011-08-15 Schering Corp Pegyliertes interleukin 10
RU2322452C2 (ru) * 2006-03-27 2008-04-20 Михаил Николаевич Смирнов Иммуномодулирующая композиция
NZ597098A (en) 2006-09-28 2013-05-31 Merck Sharp & Dohme Use of pegylated il-10 to treat cancer
EP2170394A4 (en) * 2007-06-27 2011-09-28 Joslin Diabetes Center Inc T REGULATORY LYMPHOCYTES IN ADIPOSE TISSUE
EP3348281B1 (en) 2008-12-17 2023-07-05 Merck Sharp & Dohme Corp. Mono- and di-peg il-10 production; and uses
CN105209054A (zh) 2013-04-18 2015-12-30 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
JP2016528879A (ja) 2013-06-17 2016-09-23 アルモ・バイオサイエンシーズ・インコーポレイテッド タンパク質の同一性および安定性を評価する方法
HK1226308A1 (zh) 2013-08-30 2017-09-29 Armo Biosciences, Inc. 使用白细胞介素-10治疗疾病和病症的方法
US11413332B2 (en) 2013-11-11 2022-08-16 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
KR20170068553A (ko) 2014-10-14 2017-06-19 아르모 바이오사이언시스 인코포레이티드 인터류킨-15 조성물 및 이의 용도
JP6675394B2 (ja) 2014-10-22 2020-04-01 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害の治療のためにインターロイキン−１０を使用する方法
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
US20160361415A1 (en) 2015-05-28 2016-12-15 Armo Biosciences, Inc. Methods of Using Interleukin-10 for Treating Diseases and Disorders
JP7053453B2 (ja) 2015-08-25 2022-04-12 アルモ・バイオサイエンシーズ・インコーポレイテッド 疾患及び障害を治療するためのインターロイキン１０の使用方法
EP4422668A1 (en) * 2021-10-25 2024-09-04 Ellennbe GmbH Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2068705T3 (es) * 1991-01-16 1995-04-16 Schering Corp Tratamiento de la enfermedad neoplastica con interleuquina-10.
WO1992012726A1 (en) * 1991-01-16 1992-08-06 Schering Corporation Use of interleukin-10 in adoptive immunotherapy of cancer
US5055045A (en) * 1991-03-18 1991-10-08 Dickie Robert G Disposable dental matrix retainer clamp

Also Published As

Publication number Publication date
FI962813A7 (fi) 1996-07-11
AU5842594A (en) 1995-08-08
AU707019B2 (en) 1999-07-01
PL315513A1 (en) 1996-11-12
NO963029D0 (no) 1996-07-19
PL175343B1 (pl) 1998-12-31
CN1142186A (zh) 1997-02-05
JPH09508116A (ja) 1997-08-19
FI962813A0 (fi) 1996-07-11
NZ259584A (en) 1998-01-26
EP0740552A1 (en) 1996-11-06
WO1995019780A1 (en) 1995-07-27
SK91696A3 (en) 1997-04-09
FI962813L (fi) 1996-07-11

Similar Documents

Publication Publication Date Title
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
DK545584A (da) Enzym-resistente immonumodulatoriske peptider
NO990916D0 (no) Bruk av GLP-1 eller analoger i behandlingen av myokardialt infarkt
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
DE3777253D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
EP0211354A3 (en) Nucleosides and their use as antineoplastic agents
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
GB2187955B (en) Improvements in or relating to the treatment of sickle cell disease
NO963029D0 (no) Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod
ATE253117T1 (de) Adenovirus e4 proteine für induktion von zelltod
WO2000004863A3 (en) Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
DE3875306D1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
DE3778587D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
HU9201197D0 (en) Protection from shock subsequent to injury by double-stranded rns
DE3373978D1 (en) Composition for the care or treatment of the human skin
PT1032402E (pt) Uso de citicolina para o tratamento de esclerose multipla
EP0668771A4 (en) TREATMENT OF AUTOIMMUNE DISEASES BY TOLERANCE IN CELLS, TISSUES AND ORGANS.
NZ220495A (en) A2a cyclopeptan-2-ones carrier containing methotrexate compositions
JPS6485990A (en) Antihypertestoeronemia agent
EP0099057A3 (en) N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor